142 related articles for article (PubMed ID: 19309495)
1. Taurolidine reduces the tumor stimulating cytokine interleukin-1beta in patients with resectable gastrointestinal cancer: a multicentre prospective randomized trial.
Braumann C; Gutt CN; Scheele J; Menenakos C; Willems W; Mueller JM; Jacobi CA
World J Surg Oncol; 2009 Mar; 7():32. PubMed ID: 19309495
[TBL] [Abstract][Full Text] [Related]
2. New therapeutic strategies to avoid intra- and extraperitoneal metastases during laparoscopy: results of a tumor model in the rat.
Jacobi CA; Peter FJ; Wenger FA; Ordemann J; Müller JM
Dig Surg; 1999; 16(5):393-9. PubMed ID: 10567800
[TBL] [Abstract][Full Text] [Related]
3. Instillation of taurolidine/heparin after laparotomy reduces intraperitoneal tumour growth in a colon cancer rat model.
Opitz I; Van der Veen H; Witte N; Braumann C; Mueller JM; Jacobi CA
Eur Surg Res; 2007; 39(3):129-35. PubMed ID: 17337889
[TBL] [Abstract][Full Text] [Related]
4. The influence of adhesion prophylactic substances and taurolidine/heparin on local recurrence and intraperitoneal tumor growth after laparoscopic-assisted bowel resection of colon carcinoma in a rat model.
Opitz I; van der Veen HC; Braumann C; Ablassmaier B; Führer K; Jacobi CA
Surg Endosc; 2003 Jul; 17(7):1098-104. PubMed ID: 12712383
[TBL] [Abstract][Full Text] [Related]
5. RandomiSed clinical trial assessing Use of an anti-inflammatoRy aGent in attenUating peri-operatiVe inflAmmatioN in non-meTastatic colon cancer - the S.U.R.G.U.V.A.N.T. trial.
Redmond HP; Neary PM; Jinih M; O'Connell E; Foley N; Pfirrmann RW; Wang JH; O'Leary DP
BMC Cancer; 2018 Aug; 18(1):794. PubMed ID: 30081854
[TBL] [Abstract][Full Text] [Related]
6. Influence of intraperitoneal and systemic application of taurolidine and taurolidine/heparin during laparoscopy on intraperitoneal and subcutaneous tumour growth in rats.
Braumann C; Ordemann J; Wildbrett P; Jacobi CA
Clin Exp Metastasis; 2000; 18(7):547-52. PubMed ID: 11688959
[TBL] [Abstract][Full Text] [Related]
7. Peritoneal taurolidine lavage in children with localised peritonitis due to appendicitis.
Schneider A; Sack U; Rothe K; Bennek J
Pediatr Surg Int; 2005 Jun; 21(6):445-8. PubMed ID: 15902475
[TBL] [Abstract][Full Text] [Related]
8. Local and systemic chemotherapy with taurolidine and taurolidine/heparin in colon cancer-bearing rats undergoing laparotomy.
Braumann C; Ordemann J; Kilian M; Wenger FA; Jacobi CA
Clin Exp Metastasis; 2003; 20(5):387-94. PubMed ID: 14524527
[TBL] [Abstract][Full Text] [Related]
9. Taurolidine peritoneal lavage as prophylaxis against infection after elective colorectal surgery.
Baker DM; Jones JA; Nguyen-Van-Tam JS; Lloyd JH; Morris DL; Bourke JB; Steele RJ; Hardcastle JD
Br J Surg; 1994 Jul; 81(7):1054-6. PubMed ID: 7922063
[TBL] [Abstract][Full Text] [Related]
10. Is Taurolidine a candidate for treatment of rheumatoid arthritis?
Marcinkiewicz J; Głuszko P; Kontny E; Kwaśny-Krochin B; Bobek M; Wierzchowski W; Ciszek M; Maśliński W
Clin Exp Rheumatol; 2007; 25(2):211-8. PubMed ID: 17543144
[TBL] [Abstract][Full Text] [Related]
11. Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters.
Winnicki W; Herkner H; Lorenz M; Handisurya A; Kikić Ž; Bielesz B; Schairer B; Reiter T; Eskandary F; Sunder-Plassmann G; Sengoelge G
Kidney Int; 2018 Mar; 93(3):753-760. PubMed ID: 28890326
[TBL] [Abstract][Full Text] [Related]
12. Influence of different gases and intraperitoneal instillation of antiadherent or cytotoxic agents on peritoneal tumor cell growth and implantation with laparoscopic surgery in a rat model.
Jacobi CA; Wildbrett P; Volk T; Müller JM
Surg Endosc; 1999 Oct; 13(10):1021-5. PubMed ID: 10526040
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory effects of taurine derivatives (taurine chloramine, taurine bromamine, and taurolidine) are mediated by different mechanisms.
Marcinkiewicz J; Kurnyta M; Biedroń R; Bobek M; Kontny E; Maśliński W
Adv Exp Med Biol; 2006; 583():481-92. PubMed ID: 17153635
[TBL] [Abstract][Full Text] [Related]
14. Effect of the antiendotoxic agent, taurolidine, in the treatment of sepsis syndrome: a placebo-controlled, double-blind trial.
Willatts SM; Radford S; Leitermann M
Crit Care Med; 1995 Jun; 23(6):1033-9. PubMed ID: 7774213
[TBL] [Abstract][Full Text] [Related]
15. A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis.
Solomon LR; Cheesbrough JS; Ebah L; Al-Sayed T; Heap M; Millband N; Waterhouse D; Mitra S; Curry A; Saxena R; Bhat R; Schulz M; Diggle P
Am J Kidney Dis; 2010 Jun; 55(6):1060-8. PubMed ID: 20207458
[TBL] [Abstract][Full Text] [Related]
16. Effects of taurolidine and octreotide on port site and liver metastasis after laparoscopy in an animal model of pancreatic cancer.
Wenger FA; Kilian M; Braumann C; Neumann A; Ridders J; Peter FJ; Guski H; Jacobi CA
Clin Exp Metastasis; 2002; 19(2):169-73. PubMed ID: 11964081
[TBL] [Abstract][Full Text] [Related]
17. Taurolidine and povidone-iodine induce different types of cell death in malignant pleural mesothelioma.
Opitz I; Sigrist B; Hillinger S; Lardinois D; Stahel R; Weder W; Hopkins-Donaldson S
Lung Cancer; 2007 Jun; 56(3):327-36. PubMed ID: 17383050
[TBL] [Abstract][Full Text] [Related]
18. Oral administration of taurolidine ameliorates chronic DSS colitis in mice.
Chromik AM; Müller AM; Albrecht M; Rottmann S; Otte JM; Herdegen T; Uhl W; Mittelkötter U
J Invest Surg; 2007; 20(5):273-82. PubMed ID: 17972215
[TBL] [Abstract][Full Text] [Related]
19. The evolving role of taurolidine in cancer therapy.
Neary PM; Hallihan P; Wang JH; Pfirrmann RW; Bouchier-Hayes DJ; Redmond HP
Ann Surg Oncol; 2010 Apr; 17(4):1135-43. PubMed ID: 20039217
[TBL] [Abstract][Full Text] [Related]
20. Taurolidine--a new drug with anti-tumor and anti-angiogenic effects.
Jacobi CA; Menenakos C; Braumann C
Anticancer Drugs; 2005 Oct; 16(9):917-21. PubMed ID: 16162968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
